Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 6/20 | 0.50 |
| ▸ | ANPEP | P15144 | 2/20 | 0.40 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.40 |
| ▸ | LAP3 | P28838 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | METAP1 | P53582 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2639189 | 0.97 | FDPS (0.48) | FDPSANPEPERAP2LAP3ALDH1A1 | |
| Water SCHEMBL4629852 | 0.95 | FDPS (0.46) | FDPSANPEPERAP2LAP3ALDH1A1 | |
| SCHEMBL8983328 | 0.85 | FDPS (0.54) | FDPSANPEPERAP2LAP3ALDH1A1 | |
| SCHEMBL2533837 | 0.85 | FDPS (0.58) | FDPSLAP3ALDH1A1TDP1 | |
| SCHEMBL10785210 | 0.83 | FDPS (0.67) | FDPSANPEPERAP2 | |
| SCHEMBL2840294 | 0.76 | ANPEP (0.42) | FDPSANPEPERAP2LAP3ALDH1A1 | |
| SCHEMBL3420165 | 0.76 | — | — | |
| Water SCHEMBL21253128 | 0.74 | ANPEP (0.41) | FDPSANPEPERAP2LAP3ALDH1A1 | |
| SCHEMBL5059579 | 0.72 | FDPS (0.55) | FDPSANPEPERAP2ALDH1A1 | |
| SCHEMBL10879019 | 0.72 | ALDH1A1 (0.64) | ANPEPALDH1A1TDP1ENPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4832303-B2 | — | — | 2011-12-07 | — | — | JP | claimed |
| EP-1622567-A4 | ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | MERCK & CO INC (US) | 2009-04-29 | — | — | EP | claimed |
| JP-2006504749-A | — | — | 2006-02-09 | — | — | JP | claimed |
| EP-1622567-A2 | ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | Merck & Co., Inc. (US) | 2006-02-08 | — | — | EP | claimed |
| EP-1553957-A1 | BISPHOSPHONATES FOR THE TREATMENT OF ATHEROSCLEROSIS AND DEVICES COMPRISING THEM | Novartis AG (CH) | 2005-07-20 | — | — | EP | claimed |
| WO-2005035542-A1 | SOLID-STATE FORM OF ALENDRONATE SODIUM AND PREPARATION THEREOF | PLIVA-ISTRAZIVANJE I RAZVOJ D.O.O. (US) | 2005-04-21 | — | — | WO | claimed |
| WO-2004100874-A2 | ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | MERCK & CO., INC. (US) | 2004-11-25 | — | — | WO | claimed |
| EP-1418897-A2 | USE OF BISPHOSPHONATES IN THE TREATMENT OF BONE METASTASIS ASSOCIATED WITH PROSTATE CANCER | Novartis AG (CH) | 2004-05-19 | — | — | EP | claimed |
| WO-2004035060-A1 | BISPHOSPHONATES FOR THE TREATMENT OF ANTHEROSCLEOROSIS AND DEVICES COMPRISING THEM | NOVARTIS AG (CH) | 2004-04-29 | — | — | WO | claimed |
| EP-1390373-A1 | PROCESS FOR THE PREPARATION OF 4-AMINO-1-HYDROXYBUTYLIDENE-1, 1-BIPHOSPHONIC ACID | EOS Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ti Caret A.S. (TR) | 2004-02-25 | — | — | EP | claimed |
| EP-0779813-A1 | PHOSPHONATES AND PARATHYROID HORMONE FOR OSTEOPOROSIS | THE PROCTER & GAMBLE COMPANY (US) | 1997-06-25 | — | — | EP | claimed |
| EP-0758241-A1 | USE OF CERTAIN METHANEBISPHOSPHONIC ACID DERIVATIVES TO PREVENT PROSTHESIS LOOSENING AND PROSTHESIS MIGRATION | Novartis AG (CH) | 1997-02-19 | — | — | EP | claimed |
| WO-1996007418-A1 | PHOSPHONATES AND PARATHYROID HORMONE FOR OSTEOPOROSIS | THE PROCTER & GAMBLE COMPANY (US) | 1996-03-14 | — | — | WO | claimed |
| EP-0690719-A4 | — | — | 1996-01-24 | — | — | EP | claimed |
| EP-0690719-A1 | DRY MIX FORMULATION FOR BISPHOSPHONIC ACIDS | MERCK & CO. INC. (US) | 1996-01-10 | — | — | EP | claimed |
| WO-1995030421-A1 | USE OF CERTAIN METHANEBISPHOSPHONIC ACID DERIVATIVES TO PREVENT PROSTHESIS LOOSENING AND PROSTHESIS MIGRATION | CIBA-GEIGY AG (CH) | 1995-11-16 | — | — | WO | claimed |
| EP-0617624-A1 | TREATMENT OF PERIODONTAL DISEASE WITH ALENDRONATE. | MERCK & CO INC (US) | 1994-10-05 | — | — | EP | claimed |
| WO-1994012200-A1 | DRY MIX FORMULATION FOR BISPHOSPHONIC ACIDS | MERCK & CO., INC. (US) | 1994-06-09 | — | — | WO | claimed |
| EP-0563096-A1 | NOVEL METHYLENEBISPHOSPHONIC ACID DERIVATIVES | LEIRAS OY (FI) | 1993-10-06 | — | — | EP | claimed |
| WO-1993011774-A1 | TREATMENT OF PERIODONTAL DISEASE WITH ALENDRONATE | MERCK & CO., INC. (US) | 1993-06-24 | — | — | WO | claimed |